Amyotrophic lateral sclerosis: moving towards a new classification system

被引:283
作者
Al-Chalabi, Ammar [1 ]
Hardiman, Orla [2 ]
Kiernan, Matthew C. [3 ,4 ]
Chio, Adriano [5 ]
Rix-Brooks, Benjamin [6 ,7 ]
van den Berg, Leonard H. [8 ]
机构
[1] Kings Coll London, Dept Basic & Clin Neurosci, Maurice Wohl Clin Neurosci Inst, London, England
[2] Trinity Coll Dublin, Acad Unit Neurol, Inst Biomed Sci, Dublin, Ireland
[3] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia
[4] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
[5] Univ Turin, Rita Levi Montalcini Dept Neurosci, Turin, Italy
[6] Carolinas Healthcare Syst, Neurosci Inst, Dept Neurol, Carolinas Neuromuscular ALS MDA Ctr,Carolinas Med, Charlotte, NC USA
[7] Univ N Carolina, Sch Med, Charlotte Campus, Charlotte, NC USA
[8] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol, Utrecht, Netherlands
基金
爱尔兰科学基金会; 英国医学研究理事会; 英国经济与社会研究理事会;
关键词
MOTOR-NEURON DISEASE; EL ESCORIAL CRITERIA; PROGRESSIVE MUSCULAR-ATROPHY; GENOME-WIDE ASSOCIATION; FRONTOTEMPORAL DEMENTIA; NATURAL-HISTORY; AWAJI CRITERIA; ADULT-ONSET; FLAIL ARM; ELECTRODIAGNOSTIC CRITERIA;
D O I
10.1016/S1474-4422(16)30199-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Amyotrophic lateral sderosis is a progressive adult-onset neurodegenerative disease that primarily affects upper and lower motor neurons, but also frontotemporal and other regions of the brain. The extent to which each neuronal population is affected varies between individuals. The subsequent patterns of disease progression form the basis of diagnostic criteria and phenotypic classification systems, with considerable overlap in the clinical terms used. This overlap can lead to confusion between diagnosis and phenotype. Formal classification systems such as the El Escorial criteria and the International Classification of Diseases are systematic approaches but they omit features that are important in clinical management, such as rate of progression, genetic basis, or functional effect. Therefore, many neurologists use informal classification approaches that might not be systematic, and could include, for example, anatomical descriptions such as flail-arm syndrome. A new strategy is needed to combine the benefits of a systematic approach to classification with the rich and varied phenotypic descriptions used in clinical practice.
引用
收藏
页码:1182 / 1194
页数:13
相关论文
共 125 条
  • [11] Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials
    Balendra, Rubika
    Jones, Ashley
    Jivraj, Naheed
    Steen, I. Nick
    Young, Carolyn A.
    Shaw, Pamela J.
    Turner, Martin R.
    Leigh, P. Nigel
    Al-Chalabi, Ammar
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (01) : 45 - 49
  • [12] Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS
    Barbeito, Ana G.
    Martinez-Palma, Laura
    Vargas, Marcelo R.
    Pehar, Mariana
    Manay, Nelly
    Beckman, Joseph S.
    Barbeito, Luis
    Cassina, Patricia
    [J]. NEUROBIOLOGY OF DISEASE, 2010, 37 (03) : 574 - 580
  • [13] A CONTROLLED TRIAL OF RILUZOLE IN AMYOTROPHIC-LATERAL-SCLEROSIS
    BENSIMON, G
    LACOMBLEZ, L
    MEININGER, V
    BOUCHE, P
    DELWAIDE, C
    COURATIER, P
    BLIN, O
    VIADER, F
    PEYROSTPAUL, H
    DAVID, J
    MALOTEAUX, JM
    HUGON, J
    LATERRE, EC
    RASCOL, A
    CLANET, M
    VALLAT, JM
    DUMAS, A
    SERRATRICE, G
    LECHEVALLIER, B
    PEUCH, AJ
    NGUYEN, T
    SHU, C
    BASTIEN, P
    PAPILLON, C
    DURRLEMAN, S
    LOUVEL, E
    GUILLET, P
    LEDOUX, L
    ORVOENFRIJA, E
    DIB, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (09) : 585 - 591
  • [14] Sensitivity and specificity of the 'Awaji' electrodiagnostic criteria for amyotrophic lateral sclerosis: Retrospective comparison of the Awaji and revised El Escorial criteria for ALS
    Boekestein, Werner A.
    Kleine, Bert U.
    Hageman, G.
    Schelhaas, Helenius J.
    Zwarts, Machiel J.
    [J]. AMYOTROPHIC LATERAL SCLEROSIS, 2010, 11 (06): : 497 - 501
  • [15] Brain W., 1962, MOTOR NEURONE DIS
  • [16] Brain W., 1933, AMYOTROPHIC LATERAL
  • [17] Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD)
    Brettschneider, Johannes
    Del Tredici, Kelly
    Irwin, David J.
    Grossman, Murray
    Robinson, John L.
    Toledo, Jon B.
    Fang, Lubin
    Van Deerlin, Vivianna M.
    Ludolph, Albert C.
    Lee, Virginia M. -Y.
    Braak, Heiko
    Trojanowski, John Q.
    [J]. ACTA NEUROPATHOLOGICA, 2014, 127 (03) : 423 - 439
  • [18] Stages of pTDP-43 Pathology in Amyotrophic Lateral Sclerosis
    Brettschneider, Johannes
    Del Tredici, Kelly
    Toledo, Jon B.
    Robinson, John L.
    Irwin, David J.
    Grossman, Murray
    Suh, EunRan
    Van Deerlin, Vivianna M.
    Wood, Elisabeth M.
    Baek, Young
    Kwong, Linda
    Lee, Edward B.
    Elman, Lauren
    McCluskey, Leo
    Fang, Lubin
    Feldengut, Simone
    Ludolph, Albert C.
    Lee, Virginia M. -Y.
    Braak, Heiko
    Trojanowski, John Q.
    [J]. ANNALS OF NEUROLOGY, 2013, 74 (01) : 20 - 38
  • [19] Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis
    Brettschneider, Johannes
    Libon, David J.
    Toledo, Jon B.
    Xie, Sharon X.
    McCluskey, Leo
    Elman, Lauren
    Geser, Felix
    Lee, Virginia M. -Y.
    Grossman, Murray
    Trojanowski, John Q.
    [J]. ACTA NEUROPATHOLOGICA, 2012, 123 (03) : 395 - 407
  • [20] ALS-Plus - Where does it begin, where does it end?
    Brooks, Benjamin Rix
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 345 (1-2) : 1 - 2